All News

With the end of easy oil, French oil services giant Schlumberger Clamart Technology Centre is transforming its research and development activities.

Carlos Moreira, co-founder and chairman of Swiss data-encryption firm WISekey, talks to Science|Business editor Richard L. Hudson on the travails of entrepreneurship.

Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.

Civo BioScreening is looking for strategic partnerships to help it take forward its novel polymer screening technology.

Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.

Economic disparity across Europe's regions can be linked directly to investment in research and development and adoption of information technologies, says an official report.

The Cambridge-MIT Institute has spun out its Communications Research Network project as a company to step up the pace of innovation in communications.

Funds should start flowing at the start of 2007 in the €50 billion Framework Programme 7 after the European Parliament approved the budget.

York University's Centre for Novel Agricultural Products has won a grant from the Bill & Melinda Gates Foundation to complete research into an antimalarial plant.

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

Wine and biotechnology come together in yet another genome project.

European Union has voted to continue funding embryonic stem cell research after a heated debate at the European Parliament on Tuesday.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

The future of European Union funded embryonic stem cell research hangs in the balance after a heated debate at the European Parliament on Tuesday.

A spin off from ETH-Zürich has devised a new generation of detection equipment that could help in the fight against terrorism. The company is now seeking investment and possible partnerships to take the technology to a commercial level.